National Research Corporation (NRC) Company Overview

What does NRC Health do?

National Research Corporation, now doing business publicly as NRC Health, is a Nasdaq-listed healthcare experience-management company under ticker NRC. It helps hospitals, health systems, medical groups, and other care organizations collect feedback, interpret patient and consumer sentiment, track reputation, support compliance surveying, and convert experience data into operational action. The company's current identity is therefore closer to a specialized healthcare software, analytics, and advisory platform than to a traditional market-research agency.

Which problems does the platform solve?

NRC Health's platform addresses four linked management problems: listening to patients and employees across channels, understanding unstructured and structured feedback, helping staff act on that information, and improving loyalty or reputation over time. Its official experience-management solutions span patient, consumer, employee, and market experience. The platform includes real-time feedback, CAHPS-related compliance surveying, conversational listening, reputation tools, market insight, employee experience, and analytics designed for healthcare workflows.

The economic customer is usually an enterprise healthcare organization rather than an individual patient. That matters because procurement cycles are longer, product integrations can become embedded in operating routines, and contract value often expands when a customer adopts more modules, facilities, or service lines. In practical terms, NRC Health sells a combination of software access, benchmark data, research capability, implementation support, and ongoing advisory expertise.

Why does NRC Health matter in healthcare?

Healthcare providers compete on trust, access, quality perception, digital convenience, and the consistency of thousands of human interactions. Experience data can influence retention, referrals, brand strength, service recovery, and management priorities. NRC Health positions its “Human Understanding” philosophy as a way to combine those signals into a more complete picture of the individual. The official platform description emphasizes collecting feedback, analyzing natural-language data, and delivering insights across patients, consumers, employees, and communities.

How does NRC Health make money?

NRC Health earns most of its revenue through renewable subscription-based service agreements. In FY2025, subscription revenue was $125.6 million out of $137.4 million total revenue, while the remainder came from fixed, non-subscription arrangements. Subscription contracts generally run for one to three years or longer, and revenue is commonly recognized ratably as NRC Health stands ready to provide tools, reporting, and services throughout the contract term. This creates more visibility than a project-only consulting model, although renewal, expansion, and implementation timing still affect growth.

What drives contract value and revenue growth?

The central forward-looking commercial metric is Total Recurring Contract Value, or TRCV. It represents the estimated annualized value of recurring contracts and is useful because reported revenue can lag bookings when contracts start later or ramp over time. NRC Health ended FY2025 with TRCV of $144.1 million, up 8% from $133.2 million in FY2024. By March 31, 2026, TRCV reached $152.1 million, up 13% year over year and higher for a sixth consecutive quarter. The company also announced that it had signed the largest deal in its 45-year history, an important signal that enterprise contract size may be increasing.

How does the revenue engine work operationally?

What did NRC Health's latest quarter show?

The quarter ended March 31, 2026 was strategically encouraging but financially mixed. Revenue returned to year-over-year growth for the first time since 2023, rising 4% to $34.8 million. TRCV accelerated to a record $152.1 million. However, higher selling, general, and administrative expense, depreciation, stock compensation, and interest expense reduced GAAP profitability. The official Q1 2026 earnings release therefore shows the central tension in the current story: commercial momentum is improving faster than near-term reported earnings.

Why did profit fall while revenue rose?

Direct expense increased modestly to $13.6 million, but SG&A rose to $13.4 million from $10.4 million. Depreciation and amortization climbed to $2.2 million from $1.5 million, and non-cash stock compensation was $1.6 million versus $0.2 million. Interest expense also increased to $1.3 million. These are not all equally persistent, but together they explain why operating income fell 35% even as revenue grew. The latest Form 10-Q is especially useful because it separates the improving contract pipeline from the current cost base.

The 2025 reset explains today's margin debate

FY2025 was a transition year. Revenue declined 4% to $137.4 million from $143.1 million in FY2024, and operating income dropped to $22.6 million from $35.2 million. Net income fell to $11.6 million from $24.8 million. At the same time, year-end TRCV rose 8%, capital expenditures declined, and the company changed leadership and incentive structures. The result is a business with better forward bookings but weaker recent GAAP earnings.

What changed in the cost structure?

Direct expense fell in FY2025, partly reflecting automation and lower-cost technology support, but SG&A increased by nearly $9.9 million. Depreciation and amortization also rose by $1.6 million. The company was investing in leadership, sales, product development, and a revised commercial model while absorbing the lag between contract signing and revenue recognition. This mix explains why the business can show rising TRCV and falling annual profit at the same time.

How should researchers interpret the annual report?

The FY2025 Form 10-K supports three conclusions. First, NRC Health remains a subscription-heavy business with valuable recurring relationships. Second, its 2023-2025 financial trend was negative on revenue and margins. Third, 2025 bookings improved enough to create a plausible recovery path. A strong analysis therefore cannot rely only on the latest quarter or only on the historical income statement; it must connect bookings, revenue recognition, expenses, and cash generation.

Which strategic turning points shaped NRC Health?

NRC Health's history matters because its moat comes from accumulated healthcare expertise, benchmark data, relationships, and workflow knowledge rather than from a single patented product. The company has repeatedly repositioned itself as the industry moved from mailed surveys and periodic research toward real-time, digital, integrated experience management.

1. 1981
   Michael Hays founded the company, establishing the healthcare-research base that still supports its domain credibility.
2. 1990s
   The company expanded standardized healthcare measurement and benchmarking, creating repeatable offerings rather than relying only on custom research.
3. 2000s
   Broader patient, consumer, workforce, and governance products increased cross-selling opportunities within health systems.
4. 2010s
   Digital feedback, loyalty analytics, reputation management, and real-time measurement shifted the model toward recurring software-enabled services.
5. 2021
   The capital and governance structure was simplified to a single class of common stock, making ownership easier to interpret.
6. 2024-2025
   Product, technology, and commercial investments were increased as revenue contracted, creating near-term margin pressure.
7. May 2025
   Trent Green became chief executive officer while founder Michael Hays moved to chair, marking a major leadership transition.
8. 2026
   TRCV exceeded $152 million and the company announced its largest contract, suggesting the reset may be producing commercial results.

What did the leadership transition change?

Founder-led organizations often carry strong culture and strategic continuity but also succession risk. NRC Health's 2025 transition retained Michael Hays as board chair while placing Trent Green in the chief executive role. The arrangement preserves founder influence and institutional knowledge, yet it also creates a clearer operating mandate for the new CEO. The 2026 proxy states that Hays founded the company in 1981, served as CEO until May 2025, and became chair in June 2025.

Why is history relevant to the moat?

The value of an experience platform depends not only on software features but also on the quality of benchmarks, the credibility of survey methodology, the relevance of healthcare-specific workflows, and the trust required to handle sensitive feedback. Decades of customer relationships can support all four. However, history is not sufficient by itself: large software vendors can invest heavily, health systems can consolidate vendors, and newer tools can accelerate natural-language analysis. NRC Health must translate heritage into faster product development and measurable customer outcomes.

What gives NRC Health a competitive advantage?

Are switching costs real?

Switching costs are meaningful but not absolute. A large health system may integrate NRC Health into survey distribution, dashboards, service recovery, executive reporting, reputation workflows, and compliance processes. Replacing those systems requires migration, retraining, data continuity work, and organizational change. Yet customers can still run competitive tenders, reduce scope, bring analysis in-house, or choose broader enterprise platforms. The moat is strongest where NRC Health combines software, benchmarks, advisory expertise, and reliable execution.

Who are the main competitors?

Competition comes from several directions: healthcare-specialist experience vendors, broad customer-experience platforms, survey and research firms, reputation-management products, consulting organizations, and internal analytics teams. Press Ganey is the most direct large specialist. Qualtrics and Medallia compete through broad experience-management suites. Advisory firms and healthcare technology providers can bundle adjacent capabilities. The competitive question is therefore not merely feature comparison; it is whether NRC Health can remain the best healthcare-specific system while larger rivals invest across more industries.

How financially strong is NRC Health?

NRC Health remains profitable and cash-generative, but its balance sheet has become more leveraged and less liquid than a superficial “subscription software” label might imply. At March 31, 2026, cash and cash equivalents were $2.5 million, long-term debt principal was $78.4 million, and shareholders' equity was $13.5 million. The company also reported an $18.5 million working-capital deficit. Management notes that deferred revenue materially affects working capital and believes operating cash flow plus borrowing capacity are adequate, but the low cash balance and debt load make execution important.

What does cash flow reveal?

Cash flow is healthier than net income alone suggests. FY2025 operating cash flow was $26.5 million, while capital expenditures were $10.7 million, implying approximately $15.7 million of free cash flow before acquisitions and financing. In Q1 2026, operating cash flow was $7.2 million and capex was $1.8 million, producing $5.3 million of company-defined free cash flow and a 15.4% free-cash-flow margin. Working-capital timing can create volatility, but recurring billings and non-cash charges support cash conversion.

How does capital allocation affect risk?

NRC Health funds product and growth investment while also returning cash through dividends and share repurchases. In FY2025 it spent $20.2 million on treasury-share repurchases and $11.0 million on dividends. In Q1 2026 it repurchased 109,701 shares for $1.9 million, declared a $0.16 quarterly dividend per share, and authorized a new $60 million repurchase program through March 31, 2028. Those actions can support per-share value, but they compete with debt reduction and strategic investment. With $78.4 million of term debt at March 31, 2026, capital returns should be evaluated together with leverage rather than in isolation.

Who owns NRC Health stock, and why does it matter?

NRC Health has one class of common stock with one vote per share, but ownership is not fully dispersed. The 2026 proxy reported 22.5 million shares outstanding as of March 31, 2026. CEO Trent Green beneficially owned 500,000 shares, or 2.2%, while founder and chair Michael Hays directly reported 847,299 shares, or 3.8%. More importantly, trusts and entities connected to the Hays family held substantial additional blocks disclosed in the proxy and Schedule 13D filings.

The 2026 proxy statement is the key source for ownership and governance. It shows a seven-director election slate, board committees, executive compensation design, and the founder's continuing chair role. A related Schedule 13D amendment further explains the trust and entity relationships surrounding large blocks.

Does concentrated ownership help or hurt?

It can do both. Concentrated long-term ownership can support patient investment, strategic continuity, and resistance to short-term pressure. It may also reduce the likelihood that outside institutions can quickly redirect strategy. For minority shareholders, the critical questions are whether the board remains independent in practice, whether capital allocation is disciplined, and whether executive incentives reward durable contract growth, margins, and cash flow rather than only headline bookings.

Which KPIs matter most for NRC Health?

Because NRC Health reports one segment, operational KPIs are more useful than a conventional segment-revenue table. The most important set links bookings, revenue conversion, profitability, customer economics, and capital intensity.

What opportunities and risks could change the story?

Where could growth come from?

The strongest opportunity is deeper penetration of large health systems. NRC Health can expand from a single survey or reputation product into a broader experience platform that covers patients, consumers, employees, markets, and service recovery. The company's listening platform supports multiple channels, including SMS, email, IVR, phone, portals, websites, apps, QR codes, and online reviews. More channels create more data, and more data can increase the value of analytics and workflow tools.

Other opportunities include AI-assisted analysis of unstructured feedback, integration with electronic health records and enterprise systems, employee-experience expansion, reputation products, and market-intelligence services. Consolidation among hospitals may reduce the number of customers but increase average contract size. The record TRCV and largest-ever contract suggest that NRC Health may be benefiting from this enterprise trend.

What risks are most material?

The 2025 annual report identifies risks around competition, customer consolidation, renewal and pricing pressure, technology performance, cybersecurity, data privacy, dependence on key personnel, and the ability to develop new offerings. NRC Health also relies on third-party systems and must maintain trust while handling sensitive healthcare-related information. A security incident or prolonged service failure could damage customer relationships even without a direct clinical role.

Financial risk has also increased. Higher debt raises interest expense, while continued dividends and repurchases reduce cash available for deleveraging. The working-capital deficit is partly structural because customers pay in advance and deferred revenue is a liability, but low cash still reduces room for error. Finally, the company must manage succession: the new CEO needs freedom to execute while preserving the domain expertise and customer relationships associated with the founder-led era.

Why does NRC Health matter for valuation?

A DCF for NRC Health should not start with a simple extrapolation of FY2025 earnings. The most important variables are TRCV growth, the lag from contract signing to revenue recognition, normalized operating margin, capital expenditures, working-capital timing, debt service, and the pace of capital returns. The latest period creates a wide range of plausible outcomes because bookings are improving while GAAP margins remain below historical levels.

Which assumptions deserve the most sensitivity analysis?

Revenue growth and operating margin should be tested together, not independently. A model that assumes stronger growth but no incremental servicing cost may overstate value; a model that anchors permanently to the depressed FY2025 margin may understate recovery potential. Free-cash-flow conversion also deserves separate scenarios because lower capex helped Q1 2026. Finally, discount-rate sensitivity matters more when leverage is meaningful and the company is in a transition period.

What is the key takeaway from NRC Health analysis?

NRC Health is a specialized healthcare experience platform with a high subscription mix, long-standing customer relationships, domain-specific benchmarks, and a credible position in patient and consumer insight. Its importance comes from helping health systems turn feedback into operational, reputational, and loyalty decisions. The company is not dominant because of sheer size; it competes through specialization, trust, embedded workflows, and accumulated healthcare knowledge.

The strongest evidence supporting the story is commercial: TRCV rose to a record $152.1 million in Q1 2026, increased 13% year over year, and included the largest contract in company history. Revenue returned to growth and free cash flow improved. The main weaknesses are equally clear: FY2025 revenue and earnings fell, Q1 2026 GAAP margins compressed, debt is significant relative to cash and equity, and capital returns compete with deleveraging.